filmov
tv
What are Myeloproliferative Neoplasms? For Patients & Caregivers from Top MPN Specialist
Показать описание
You or a loved one has just been diagnosed with a subtype of myeloproliferative neoplasms or MPN, but what does that mean? Is it essential thrombocythemia, polycythemia vera, or myelofibrosis? What treatment options are out there for you, especially if you don’t have access to an MPN specialist?
Featuring:
Dr. Ruben Mesa
Executive Director of Mays Cancer Center
Director of UT Health San Antonio MD Anderson Cancer Center
Myeloproliferative Neoplasms (MPNs) Specialist
In this Series: Dr. Mesa covers the latest updates focused on MPNs following the biggest blood cancer/disease conference (ASH) held at the end of 2021 that looked forward to emerging treatments studied in 2022 and beyond.
Videos:
The interview has only been edited for clarity.
Join Our Community:
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
____________________________
#ThePatientStory #bloodcancer #blooddisease #hematology #oncology #MPN #myeloproliferativeneoplasms #essentialthrombocythemia #polycythemiavera #clinicaltrials #relapsedrefractory #Patientcare #cancertreatment #Cartcelltherapy
Featuring:
Dr. Ruben Mesa
Executive Director of Mays Cancer Center
Director of UT Health San Antonio MD Anderson Cancer Center
Myeloproliferative Neoplasms (MPNs) Specialist
In this Series: Dr. Mesa covers the latest updates focused on MPNs following the biggest blood cancer/disease conference (ASH) held at the end of 2021 that looked forward to emerging treatments studied in 2022 and beyond.
Videos:
The interview has only been edited for clarity.
Join Our Community:
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
____________________________
#ThePatientStory #bloodcancer #blooddisease #hematology #oncology #MPN #myeloproliferativeneoplasms #essentialthrombocythemia #polycythemiavera #clinicaltrials #relapsedrefractory #Patientcare #cancertreatment #Cartcelltherapy
0:09:00
Myeloproliferative Neoplasms (MPNs) - Myeloproliferative Disorders - CML, PV, ET, PMF
0:06:04
What are Myeloproliferative Neoplasms? For Patients & Caregivers from Top MPN Specialist
0:01:25
What Are Myeloproliferative Neoplasms (MPNs)?
0:04:05
Overview of Myeloproliferative Neoplasms
0:06:13
Blood Review Series – Myeloproliferative Neoplasms
0:02:03
MYELOPROLIFERATIVE NEOPLASMS: What’s happening inside the body
0:00:59
Are myeloproliferative neoplasms (MPNs) cancer?
0:06:42
Differentiating Between Myeloproliferative Neoplasms
0:04:19
Myeloproliferative neoplasms in young patients
0:01:30
Managing Symptoms For Patients With Myeloproliferative Neoplasms
0:04:00
Explaining Myeloproliferative Neoplasm Disease Progression to Patients
0:02:03
Treating Myeloproliferative Neoplasms (MPNs)
0:03:19
ASH 2022: MPNs, or Myeloproliferative Neoplasms with Dr. Gabriela Hobbs
0:07:58
Essential Thrombocytosis (ET) | Myeloproliferative Neoplasm (JAK2 Kinase)
0:00:50
Introduction to Myeloproliferative Neoplasms (MPNs)
0:07:05
Chronic MPN (Myeloproliferative Neoplasms) Update
0:03:11
Managing Fatigue in Myeloproliferative Neoplasms
0:02:53
What Are Myeloproliferative Neoplasms (MPNs)?
0:01:45
What's new in myeloproliferative neoplasms?
0:04:52
An Overview of Myeloproliferative Neoplasms
0:05:29
Managing Myeloproliferative Neoplasms MPN
0:50:19
The Genetic Basis of Myeloproliferative Neoplasms and Its Clinical Relevance
1:05:34
Understanding Myeloproliferative Neoplasms WEBINAR
0:07:19
Hematological malignancies – Part 1b: Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Комментарии